Posters

Posterior capsule opacification evolution in Clareon intraocular lenses

Poster Details

First Author: F.Bartol-Puyal SPAIN

Co Author(s):    C. Almenara Michelena   D. Soriano Pina   M. Chacón González   J. Larrosa Poves   V. Polo Llorens   L. Pablo Júlvez     

Abstract Details

Purpose:

To evaluate the posterior capsule opacification (PCO) evolution in intraocular lenses (IOL) from the platform Clareon (Alcon) between one and twelve months after implantation during cataracts surgery.

Setting:

Miguel Servet University Hospital, Zaragoza, Spain.

Methods:

60 eyes of 60 patients implanted with Clareon IOL and with an axial length (AL) between 22 and 25 mm were examinated. Exclusion criteria were: amblyopia, ocular disorders, previous ophthalmological treatment, and intra or postoperative complications. The following tests were performed one and twelve months after cataracts surgery: mesopic visual acuity (VA), CSV-1000E under mesopia, KR-1W (4 mm without pharmacological mydriasis and 6mm under pharmacological mydriasis), OQAS, Catquest-9SF questionnaire and slit-lamp pictures taken by the same technician and under pharmacological mydriasis. OCP was quantified between 0 and 5, and the area was measured using ImageJ (NIH).

Results:

Mean age was 71.73±8.44 years, mean AL was 23.53±0.91 mm and mean IOL power was 21.28±2.44 D. The Strehl ratio decreased from 0.15±0.04 to 0.05±0.01 (p=0.02). No differences were found regarding the other examinations. No differences were found in the intensity of PCO, nor in its area.

Conclusions:

Patients with Clareon IOL do not experience a significative increase in PCO during the first twelve months after implantation, which could imply any subjective or objective alterations.

Financial Disclosure:

None